– Orphan designation in E.U. supports development of treatments for life-threatening or chronically debilitating conditions with significant unmet medical need – – Phase 2 SOLSTICE 24-week primary ...
The delta variant of SARS-CoV-2, the virus that causes COVID-19, has been making headlines as it has quickly become the most prevalent strain in America. But other variants of the virus are still out ...
Hosted on MSN
Original COVID-19 vaccination did not stop immune system from fighting variants, finds study
Prior COVID-19 vaccination did not stop the immune system from mounting a protective response to the delta and omicron strains, though new mutation-specific antibody production dipped slightly, ...
Findings showed 100% of participants taking the tobevibart and elebsiran combination achieved an undetectable HDV RNA at week 24 that was sustained through week 60. The Food and Drug Administration ...
CEO Marianne De Backer emphasized Vir's progress in advancing its infectious disease and oncology programs. Key milestones include initiating the ECLIPSE Phase III registrational program for hepatitis ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results